knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 06:43:56 - browse：18145

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： PBM reform efforts get punted in Congress

WSS

NIH study of ME/CFS points to clear biological hallmarks

Bird flu outbreak in cows is latest avian flu curveball

A solution to the after

A solution to the after

Why rehabilitation engineers need to center patients in their research

Cancer researcher Catriona Jamieson is sending tumors into space

focus

knowledge

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cholera vaccine supply gets boost as demand surges globally

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Harvard botanist who searched for psychedelics in the Amazon

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH study of ME/CFS points to clear biological hallmarks

In age of alternative facts, a scholarly course on calling out crap

NIH study of ME/CFS points to clear biological hallmarks

In age of alternative facts, a scholarly course on calling out crap

Antivenom research: Lessons from HIV applied in search for universal antidote

leisure time

PBM reform efforts get punted in Congress

Health care needs a new profession: neuroimaging counseling

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

The Harvard botanist who searched for psychedelics in the Amazon

Cell therapy fails to slow type 1 diabetes, but safety is established

focus

hotspot

focus

focus